AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
LENACAPAVIR in Zimbabwe
2 products registered with MCAZ — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LENACAPAVIR GILEAD TABLET, COATED; ORAL | 2025/7.13/7229 | GILEAD SCIENCES IRELAND UC, | active | 18 Nov 2030 |
| LENACAPAVIR GILEAD SOLUTION; INJECTION | 2025/7.13/7230 | GILEAD SCIENCES IRELAND UC, | active | 18 Nov 2030 |
LENACAPAVIR — MCAZ Registration Details
MCAZ (Zimbabwe) has 2 registered products containing LENACAPAVIR, of which 2 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track LENACAPAVIR registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.